Status:
COMPLETED
Prospective Multicenter Study to Characterize the REAL-WORLD EVIDENCE Regarding Safety and Performance of the PTCA Catheters Family
Lead Sponsor:
Arthesys
Conditions:
Coronary Artery Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this Post market Study is to collect clinical data of the Arthesys PTCA catheters family during angioplasty intervention of coronary vessels or coronary bypass graft stenosis to support...
Eligibility Criteria
Inclusion
- Patient with a Percutaneous intervention to a native coronary or coronary bypass graft indication
- Patient \>18 years
- Patient who understands the trial requirements and the treatment procedures and provides written informed consent
Exclusion
- \- Patients will not be included if they are under judicial protection, guardianship or curatorship or if they are deprived of their liberty by judicial or administrative decision.
Key Trial Info
Start Date :
July 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05232565
Start Date
July 29 2022
End Date
July 15 2023
Last Update
July 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint Louis
La Rochelle, France, 17000